This evidence, together with the fact that TP53 mutations are more frequent in EGFR-mutated patients, suggest that some of these oncogene-addicted tumors could possess an underlying biology and molecular mechanisms based on two main biomarkers to guide cancer progression [5,108]. Here, TP53 is linked to cancer.